OPTIVAR

This page contains recent news articles, when available, and an overview of OPTIVAR but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Meda AB (publ) - Interim report, January -September 2009  -  ‎Nov 2, 2009‎
Optivar (allergic conjunctivitis treatment) reached SEK 323 million (260). In the US, sales in local currency increased 2%. Zamadol (moderate to severe pain ... WELT ONLINE

Meda AB (publ) - DelÃ¥rsrapport januari - september 2009  -  ‎Nov 3, 2009‎
Medas försäljning av Optivar (behandling av allergisk konjunktivit) uppgick till 323 (260) MSEK. I USA ökade försäljningen i lokal valuta med 2%. ... MyNewsdesk (pressmeddelande)

Meda to buy MedPointe for $800 mln in cash, stock  -  Jul 20, 2007
MedPointe's biggest products are non-steroidal nasal spray Astelin and the allergic conjunctivitis treatment Optivar, Meda said in a statement. ... Reuters

Meda Settles Patent Litigation With Apotex  -  Apr 29, 2008
The US subsidiary of Swedish drugmaker Meda has reached an agreement in a patent suit against Apotex over proposed generic versions of Astelin and Optivar. ... FDA news - FDA news (subscription)

Optivar.(drug overview)(Drug overview)  -  Dec 1, 2005
Optivar is taken to relieve and prevent the itchy eyes brought on by seasonal allergies. The drug usually starts to work within 3 minutes of placing the ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com

Optivar.(Drug overview)  -  Jan 22, 2007
Optivar is taken to relieve and prevent the itchy eyes brought on by seasonal allergies. The drug usually starts to work within 3 minutes of placing the ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com

MedPointe Sets Leadership Succession and Management Realignment …  -  Apr 13, 2006
In addition, our ocular antihistamine, Optivar(R), is showing record prescription growth trends, and our late-stage clinical line extension programs for ... Free with registration - Business Wire - AccessMyLibrary.com

FDA Approves Azelastine Eye Drops Unit Dose  -  Jul 8, 2008
The US Food and Drug Administration (FDA) has approved Meda's (STO:MEDAA) registration application for azelastine eye drops in unit dose (Optivar Unit Dose) ... Lifescience-online

MEDA: PATENTUPPGÖRELSE M APOTEX OM ASTELIN OCH OPTIVAR …  -  Apr 21, 2008
STOCKHOLM (Direkt) Meda har nått en uppgörelse med Apotex avseende patenttvisten för Astelin och Optivar. Uppgörelsen innebär att Apotex medger intrång på ... Dagens Nyheter

ШведÑ?каÑ? фармацевтичеÑ?каÑ? компаниÑ? Meda приобретет американÑ?к  -  Jul 20, 2007
Крупнейшими продуктами MedPointe по объему продаж Ñ?влÑ?ÑŽÑ‚Ñ?Ñ? неÑ?тероидный назальный Ñ?прей Astelin и препарат длÑ? лечениÑ? аллергичеÑ?кого конъюнктивита Optivar. ... ФармацевтичеÑ?кий веÑ?тник

New Survey Shows 80 Percent of Allergy Sufferers Are Itching for...  -  Apr 25, 2005
One option available by doctor's prescription is OPTIVAR(R) (azelastine hydrochloride ... OPTIVAR works in multiple ways to block the allergic process. ... RedOrbit

Press Release: New Survey Shows 80 Percent of Allergy Sufferers Are …  -  Apr 25, 2005
One option available by doctor's prescription is OPTIVAR(R) (azelastine hydrochloride ... OPTIVAR works in multiple ways to block the allergic process. ... Pay-Per-View - PR Newswire - HighBeam Research

IP NEXT ニュース / Medaã€?アレルギー治療薬ã?®ç‰¹è¨±ã‚’ã‚?ã??り後発薬メーカー...  -  Apr 22, 2008
...スウェーデン�製薬�業Meda AB�21日��膜炎治療薬「Optivar��鼻炎 ... ア�テックス �Astelin�Optivar�後発医薬��関�る医薬�簡略承�を米食�医薬�局(FDA) ... IP NEXT ニュース

Geografiska och produkts- synergier kommer med förvärv  -  Jul 20, 2007
MedPointes största produkter, Astelin och Optivar, innehåller den aktiva ... Optivar är ögondroppar godkända för behandling av allergisk konjunktivit. ... Affärsvärlden - Affärsvärlden

Experts explore possible treatments for seasonal allergic conjunctivit...  -  May 25, 2008
Optivar (azelastine HCl ophthalmic solution 0.05%, Meda) is a good product, ... I will give them a mast cell stabilizer/antihistamine, Optivar. ... OSN SuperSite

Paladin Resources Ltd launches a tender offer for Summit Resources...  -  Jun 1, 2007
Bowel Disease M Meda AB Paladin Labs Inc. ## Optivar (azelastine…Trial Details November ##, #### Paladin Labs Inc. and Meda AB…the terms of the Agreement, ... Pay-Per-View - deals - Alacra Store

Article: Meda settles US Astelin[R] patent litigation with Apotex.(Ind...  -  May 1, 2008
Astelin[R] (azelastine hydrochloride nasal spray) is used for treatment of allergic and non-allergic rhinitis and Optivar[R] (azelastine hydrochloride ... Pay-Per-View - Pharmaceutical Processing - HighBeam Research

FDA approves first generic versions of Lamisil tablets.(Industry...  -  Aug 1, 2007
ANDAs (Abbreviated New Drug Applications) to the FDA for generic versions of Astelin[R] and Optivar[R]in 2006 and 2007, respectively ... ... Pay-Per-View - Pharmaceutical Processing - HighBeam Research

Critical Therapeutics Announces Anne M. Fields to Head Its Specialty ...  -  Jun 30, 2006
...where she successfully grew MedPointe's key in-line brands, Astelin(R), Optivar(R) and Zomig(R). Ms. Fields spent 19 years at Schering-Plough Corp. ... Genetic Engineering News - Genetic Engineering News (press release)

Tracking Trends in Pharmacologic Therapy  -  Mar 31, 2006
Four drugs are available in this class: Olopatadine 0.1% (Patanol), ketotifen 0.025% (Zaditor), azelastine 0.05% (Optivar) and epinastine 0.05% (Elestat). ... RedOrbit

Taming Allergy Eyes  -  Aug 27, 2005
...azelastine HCl ophthalmic solution 0.05% (Optivar), olopatadine HCl (Patanol) or ketotifen fumarate ophthalmic solution 0.025% (Zaditor). ... RedOrbit

People news from the 04/14/06 News Brief  -  Apr 14, 2006
Among MedPointe's biggest products are allergy medication Astelin and Optivar for allergic conjunctivitis. Genentech made four VP appointments. ... Medical Marketing & Media - Medical Marketing and Media

Wishbone/ITP: gutsy and triumphant turnaround after losing a third of...  -  Jul 1, 2006
The three wins that helped offset the Sonata and Zomig losses came in from: MedPointe, which awarded the agency Astelin (for allergies), Optivar (eye drops ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com

CAC test compares allergic conjunctivitis medications: conjunctival …  -  Sep 1, 2005
The rest are ketotifen fumarate (Zaditor, Novartis Ophthalmics) with 8.1%, epinastine (Elestat, Inspire/Allergan) 6.5%, azelastine HCl (Optivar, Muro) 6.2%, ... Free with registration - Ophthalmology Times - AccessMyLibrary.com

MEDA 1 KV: ASTELIN SÃ…LDE FÖR 405 MKR  -  May 6, 2008
Optivar sålde för 80 miljoner kronor (21). Lageruppbyggnad i grossistledet bidrog till den starka utvecklingen. Medas försäljning av preparatet Soma uppgick ... Dagens Nyheter

MEDA: ANALYTIKER SPÃ…R EBITDA 819 MKR 1 KV - SME DIREKT (OMS …  -  May 2, 2008
Aktien har stärkts av en rad positiva nyheter under den senaste tiden varav uppgörelsen med Apotex kring allergipreparaten Astelin och Optivar toppar den ... Dagens Nyheter

Aging eye is focus of ARVO meeting in 2007: novel and existing...  -  Aug 1, 2007
Alcon Laboratories), ketotifen 0.25% (Zaditor, Novartis), azelastine 0.05% (Optivar, MedPointe Pharmaceuticals), and epinastine 0.05% (Elestat, ... Free with registration - Ophthalmology Times - AccessMyLibrary.com

BÖRSEN: BANKERNA STIGER, TELIASONERA OCH ABB NED, …  -  Apr 21, 2008
Meda A steg med 6,2 procent till 68:25 kronor efter att bolaget nått en uppgörelse med Apotex avseende patenttvisten för Astelin och Optivar. ... Dagens Nyheter

Factiva Search  -  Jan 4, 2005
Eye Health; Pharma company's expanded sales force to promote OPTIVAR. 04 January, 2005 Life Science Weekly. 2005 JAN 4 - (NewsRx.com & NewsRx.net) ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Undisclosed Acquiror acquires Sis International A/S- from Tower Group...  -  Sep 11, 2006
Optivar is complementary to MedPointe's flagship product, Astelin, and a significant addition to the Company…the acquisiti on of U.S. rights to Doral ... Pay-Per-View - deals - Alacra Store

What's in the pipeline for ocular allergy? Recent developments...  -  Mar 15, 2007
Included in this class are olopatadine HCl (Patanol, Alcon), ketotifen fumarate (Zaditor, Novartis), azelastine HCl (Optivar, MedPointe) and epinastine HCl ... Free with registration - Review of Optometry - AccessMyLibrary.com

BÖRSEN: BANKER OCH VERKSTAD LEDER NEDGÃ…NG, OMXS30 -1,1 …  -  Apr 21, 2008
...till 68:75 kronor efter att bolaget meddelat om en förlikning med generikaföretaget Apotex i patenttvisten kring allergipreparaten Astelin och Optivar. ... Dagens Nyheter

Article: You can win this Ruger M77 .30-06 and Leupold scope. - Guns ...  -  Sep 1, 2006
Optivar (azelastine HCl ophthalmic solution) 0.05%, from Tewksbury, Mass.-based Muro Pharmaceutical Inc., has just. Computer Shopper ... Pay-Per-View - Guns Magazine - HighBeam Research

Inflammatory cascade linked to allergic conjunctivitis: multi...  -  Aug 15, 2007
All five medications examined in the review article--azelastine HCl 0.05% (Optivar, MedPointe Pharmaceuticals), epinastine HCl 0.05% (Elestat, ... Free with registration - Ophthalmology Times - AccessMyLibrary.com

cortisone | Definition of cortisone | HighBeam.com: Online Dictionary  -  Jul 12, 2006
Azelastine more effective than olopatadine during in vitro study of cultured human mast cells Boston-Ophthalmic solutions of azelastine HCI (Optivar, ... Pay-Per-View - Oxford American College Dictionary - HighBeam Research

Par begins shipment of pravastatin tablets.(Industry News) | Article...  -  Nov 1, 2006
...submission of ANDAs (Abbreviated New Drug Applications) to the FDA for generic versions of Astelin[R] and Optivar[R]in 2006 and 2007, respectively ... ... Pay-Per-View - Pharmaceutical Processing - HighBeam Research

The Everything Guide to Fall Allergies - Experts Assess the Treatments...  -  Sep 14, 2008
But, panel members say, they only work for four to six hours versus twelve for Optivar, so getting a prescription may be worth it. ... New York Magazine

Swedish company buys MedPointe.(News Focus)  -  Sep 1, 2007
The acquisition will win Meda a U.S. presence, the allergy drugs Astelin (azelastine nasal spray) and Optivar (azelastine hydrochloride ophthalmic solution) ... $4.95 - Pharmaceutical Representative - ECNext

Wishbone/ITP: gutsy and triumphant turnaround after losing a third of...  -  Jul 1, 2006
The three wins that helped offset the Sonata and Zomig losses came in from: MedPointe, which awarded the agency Astelin (for allergies), Optivar (eye drops ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Kicking drugs with pot, a ceramic one  -  Jan 17, 2008
For 21 straight years I've dutifully pumped my body full of drugs with names like Zyrtec, Optivar, Astelin, Benadryl, Nasalcort, Allegra, Singulair, ... College Times

From the pharmacy.(storing Lantus)(drug therapy for Alzheimer's...  -  Mar 1, 2007
Insurance companies may opt to stop paying for prescription eye drops such as Patanol, Optivar, and Elestat since they are very similar to the new OTC ... Pay-Per-View - Saturday Evening Post - HighBeam Research

From the pharmacy.(storing Lantus)(drug therapy for Alzheimer's...  -  Mar 1, 2007
Insurance companies may opt to stop paying for prescription eye drops such as Patanol, Optivar, and Elestat since they are very similar to the new OTC ... $4.95 - Saturday Evening Post - ECNext

Minnesota - Official Notices - Department of Human Services  -  Jan 3, 2006
Optivar Ophthalmic quinolones Zymar Other BiDil Ceredase Growth Hormone Lyrica Rozerem Xolair Zanaflex (brand) capsules For services performed in physician ... Pay-Per-View - RegAlert - Factiva, from Dow Jones





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy